{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:42:32Z","timestamp":1790959352205,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.chemphyslip.2022.105177","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:22:50Z","timestamp":1643822570000},"page":"105177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Nose-to-brain lipid nanocarriers: An active transportation across BBB in migraine management"],"prefix":"10.1016","volume":"243","author":[{"given":"Ishant","family":"Kataria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Shende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemphyslip.2022.105177_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/pharmaceutics12030251","article-title":"Pharmacotechnical development of a nasal drug delivery composite nanosystem intended for alzheimer\u2019s disease treatment","volume":"12","author":"Adnet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib2","first-page":"1598","article-title":"Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles","volume":"15","author":"Baltzley","year":"2014","journal-title":"Ageing Int."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/17425247.2018.1429401","article-title":"Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery","volume":"15","author":"Battaglia","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib4","first-page":"707","article-title":"Nanoemulsion based intranasal delivery of antimigraine drugs for nose to brain targeting","volume":"71","author":"Bhanushali","year":"2009","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/head.14024","article-title":"The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys","volume":"61","author":"Burch","year":"2021","journal-title":"Headache"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017018693","article-title":"Lipid nanoparticles for nasal\/intranasal drug delivery","volume":"34","author":"Cunha","year":"2017","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib7","doi-asserted-by":"crossref","DOI":"10.2174\/1389201021666201218130947","article-title":"Advances in stem cell therapy for brain diseases via the intranasal route","author":"Dali","year":"2021","journal-title":"Curr. Pharm. Biotech."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.xphs.2018.07.013","article-title":"Intranasal drug delivery of frovatriptan succinate\u2013loaded polymeric nanoparticles for brain targeting","volume":"108","author":"Deepika","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib9","first-page":"404","article-title":"The pharmacological management of migraine, Part I overview and abortive therapy","volume":"33","author":"DeMaagd","year":"2008","journal-title":"P&T"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/pharmaceutics12050448","article-title":"Neuroprotective effect of ropinirole lipid nanoparticles enriched hydrogel for parkinson\u2019s disease: in vitro, ex vivo, pharmacokinetic and pharmacodynamic evaluation","volume":"12","author":"Dudhipala","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1208\/s12249-016-0532-0","article-title":"Multivariate optimization of rizatriptan benzoate-loaded solid lipid nanoparticles for brain targeting and migraine management","volume":"18","author":"Girotra","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib13","first-page":"105","article-title":"Animal models for intranasal drug delivery studies: a review article","volume":"2","author":"Gizurarson","year":"1990","journal-title":"Acta Pharm. Nord."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1526-4610.2006.00301.x","article-title":"Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy","volume":"46","author":"Goadsby","year":"2006","journal-title":"Headache J. Head Face Pain"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib15","first-page":"107","article-title":"Biodegradable polymeric nanoparticles are effective systems for controlled drug delivery","volume":"38","author":"G\u00fcltekin","year":"2013","journal-title":"Fabad J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5984014","article-title":"Systematic approach for the formulation and optimization of solid lipid nanoparticles of efavirenz by high pressure homogenization using design of experiments for brain targeting and enhanced bioavailability","volume":"2017","author":"Gupta","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijbiomac.2015.08.035","article-title":"Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential","volume":"81","author":"Hansraj","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.10.011","article-title":"Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression","volume":"48","author":"Haque","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120428","article-title":"Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose","volume":"599","author":"Hasan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib20","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems \u2013 a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5173(99)00412-3","article-title":"Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide","volume":"196","author":"Jacobs","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11095-009-0041-x","article-title":"Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy","volume":"27","author":"Jain","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib23","article-title":"Modulation of olfactory area for effective transportation of actives in CNS disorders","author":"Jain","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib24","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1021\/acs.molpharmaceut.6b00453","article-title":"Intranasal eutectic powder of zolmitriptan with enhanced bioavailability in the rat brain","volume":"13","author":"Khan","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijbiomac.2019.08.236","article-title":"Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method","volume":"142","author":"Khezri","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4103\/2230-973X.195927","article-title":"Formulation development and evaluation of zolmitriptan oral soluble films using 22 factorial designs","volume":"6","author":"Koteswari","year":"2016","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0169-409X(00)00122-8","article-title":"Nanoparticulate systems for brain delivery of drugs","volume":"47","author":"Kreuter","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib28","article-title":"Stability studies and characterization of SLN formulations","author":"Martins","year":"2007","journal-title":"Chemistry"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.22270\/jddt.v11i1-s.4687","article-title":"A concise review on preparation methods used for the development of solid lipid nanoparticles","volume":"11","author":"Matta","year":"2021","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12121132","article-title":"Solid lipid nanoparticles as formulative strategy to increase oral permeation of a molecule active in multidrug-resistant tuberculosis management","volume":"12","author":"Obinu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib33","first-page":"1029","article-title":"Developement and validation of a selective and rapid LC-MS\/MS method for quantification of zolmitriptan","volume":"11","author":"Paladugu","year":"2013","journal-title":"Int. J. Chem. Sci."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/17425247.2013.784742","article-title":"Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles","volume":"10","author":"Patel","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jconrel.2021.05.046","article-title":"Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier","author":"Pathan","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03639045.2017.1402918","article-title":"Development of zolmitriptan transfersomes by Box\u2013Behnken design for nasal delivery: in vitro and in vivo evaluation","volume":"44","author":"Pitta","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-5173(97)00222-6","article-title":"Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN)","volume":"157","author":"Schwarz","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s13346-013-0133-3","article-title":"Nanotechnology for CNS delivery of bio-therapeutic agents","volume":"3","author":"Shah","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.chemphyslip.2022.105177_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003495-199958020-00016","article-title":"Zolmitriptan. A review of its use in migraine","volume":"58","author":"Spencer","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/head.12181","article-title":"Intranasal zolmitriptan for the treatment of acute migraine","volume":"53","author":"Tepper","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2022.105177_bib43","first-page":"508","article-title":"Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR","volume":"60","author":"Zimmermann","year":"2005","journal-title":"Pharmazie"}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308422000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308422000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:34:34Z","timestamp":1757860474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308422000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"alternative-id":["S0009308422000056"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2022.105177","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nose-to-brain lipid nanocarriers: An active transportation across BBB in migraine management","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2022.105177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105177"}}